Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Psychological Predictors of Prostate Cancer Screening Behaviors Among Men Over 50 Years of Age in Hamadan: Perceived Threat and Efficacy.

Barati M, Amirzargar MA, Bashirian S, Kafami V, Mousali AA, Moeini B.

Iran J Cancer Prev. 2016 Jun 14;9(4):e4144. eCollection 2016 Aug.

2.

Association between polymorphisms in selected inflammatory response genes and the risk of prostate cancer.

Chen J, Ying XM, Huang XM, Huang P, Yan SC.

Onco Targets Ther. 2016 Jan 11;9:223-9. doi: 10.2147/OTT.S91420. eCollection 2016.

3.

Factors associated with prostate cancer screening behavior among men over 50 in Fasa, Iran, based on the PRECEDE model.

Jeihooni AK, Kashfi SM, Kashfi SH, Heydarabadi AB, Imanzad M, Hafez AA.

Electron Physician. 2015 Jun 5;7(2):1054-62. doi: 10.14661/2015.1054-1062. eCollection 2015 Apr-Jun.

4.

Redefining hormone sensitive disease in advanced prostate cancer.

Hou X, Flaig TW.

Adv Urol. 2012;2012:978531. doi: 10.1155/2012/978531. Epub 2012 Feb 25.

5.

Differential regulation of insulin-like growth factor-I receptor gene expression by wild type and mutant androgen receptor in prostate cancer cells.

Schayek H, Seti H, Greenberg NM, Sun S, Werner H, Plymate SR.

Mol Cell Endocrinol. 2010 Jul 29;323(2):239-45. doi: 10.1016/j.mce.2010.04.017. Epub 2010 Apr 24.

6.

beta-TrCP inhibition reduces prostate cancer cell growth via upregulation of the aryl hydrocarbon receptor.

Gluschnaider U, Hidas G, Cojocaru G, Yutkin V, Ben-Neriah Y, Pikarsky E.

PLoS One. 2010 Feb 5;5(2):e9060. doi: 10.1371/journal.pone.0009060.

7.

The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth.

Wu K, Katiyar S, Witkiewicz A, Li A, McCue P, Song LN, Tian L, Jin M, Pestell RG.

Cancer Res. 2009 Apr 15;69(8):3347-55. doi: 10.1158/0008-5472.CAN-08-3821. Epub 2009 Apr 7.

8.

Endocrine-immune-paracrine interactions in prostate cells as targeted by phytomedicines.

Gray NE, Liu X, Choi R, Blackman MR, Arnold JT.

Cancer Prev Res (Phila). 2009 Feb;2(2):134-42. doi: 10.1158/1940-6207.CAPR-08-0062. Epub 2009 Jan 13.

9.

DHEA metabolism in prostate: For better or worse?

Arnold JT.

Mol Cell Endocrinol. 2009 Mar 25;301(1-2):83-8. doi: 10.1016/j.mce.2008.10.019. Epub 2008 Nov 1. Review.

10.

Soil zinc content, groundwater usage, and prostate cancer incidence in South Carolina.

Wagner SE, Burch JB, Hussey J, Temples T, Bolick-Aldrich S, Mosley-Broughton C, Liu Y, Hebert JR.

Cancer Causes Control. 2009 Apr;20(3):345-53. doi: 10.1007/s10552-008-9248-0. Epub 2008 Oct 24.

11.

Sirtuin 1 is required for antagonist-induced transcriptional repression of androgen-responsive genes by the androgen receptor.

Dai Y, Ngo D, Forman LW, Qin DC, Jacob J, Faller DV.

Mol Endocrinol. 2007 Aug;21(8):1807-21. Epub 2007 May 15.

12.

Mechanisms of acquired androgen independence during arsenic-induced malignant transformation of human prostate epithelial cells.

Benbrahim-Tallaa L, Webber MM, Waalkes MP.

Environ Health Perspect. 2007 Feb;115(2):243-7. Epub 2006 Nov 20.

13.

Acquisition of androgen independence by human prostate epithelial cells during arsenic-induced malignant transformation.

Benbrahim-Tallaa L, Webber MM, Waalkes MP.

Environ Health Perspect. 2005 Sep;113(9):1134-9.

Supplemental Content

Support Center